Comerica Bank Ani Pharmaceuticals Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Comerica Bank holds 26,929 shares of ANIP stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,929

Previous 23,563 14.29%

Holding current value

$1.52 Million

Previous $1.5 Million 7.07%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $182,874 - $221,213	3,366 Added 14.29%	26,929 $1.61 Million
Q2 2024 Aug 15, 2024	SELL	$58.53 - $68.82 $766,743 - $901,541	-13,100 Reduced 35.73%	23,563 $1.5 Million
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $10,406 - $13,380	-192 Reduced 0.52%	36,663 $2.53 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $79,218 - $106,389	1,626 Added 4.62%	36,855 $2.03 Million
Q3 2023 Nov 21, 2023	BUY	$50.28 - $64.61 $1.77 Million - $2.28 Million	35,229 New	35,229 $2.05 Million
Q4 2022 Jan 26, 2023	SELL	$31.9 - $41.95 $20,511 - $26,973	-643 Reduced 1.34%	47,309 $0
Q3 2022 Oct 28, 2022	BUY	$29.83 - $38.01 $1.1 Million - $1.4 Million	36,767 Added 328.72%	47,952 $1.77 Million
Q2 2022 Aug 02, 2022	SELL	$23.09 - $33.46 $230 - $334	-10 Reduced 0.09%	11,185 $354,000
Q1 2022 Apr 27, 2022	BUY	$26.91 - $47.15 $71,446 - $125,183	2,655 Added 31.09%	11,195 $314,000
Q4 2021 Feb 18, 2022	BUY	$32.97 - $56.85 $5,868 - $10,119	178 Added 2.13%	8,540 $393,000
Q3 2021 Nov 22, 2021	SELL	$26.48 - $35.99 $10,433 - $14,180	-394 Reduced 4.5%	8,362 $274,000
Q2 2021 Aug 26, 2021	SELL	$31.86 - $38.6 $17,427 - $21,114	-547 Reduced 5.88%	8,756 $306,000
Q1 2021 Apr 28, 2021	SELL	$28.4 - $36.14 $11,076 - $14,094	-390 Reduced 4.02%	9,303 $336,000
Q4 2020 Jan 28, 2021	BUY	$23.69 - $31.47 $1,563 - $2,077	66 Added 0.69%	9,693 $281,000
Q3 2020 Oct 30, 2020	SELL	$26.38 - $33.1 $1,530 - $1,919	-58 Reduced 0.6%	9,627 $271,000
Q2 2020 Jul 31, 2020	BUY	$29.93 - $50.1 $20,891 - $34,969	698 Added 7.77%	9,685 $313,000
Q1 2020 May 01, 2020	BUY	$30.35 - $67.14 $7,466 - $16,516	246 Added 2.81%	8,987 $366,000
Q4 2019 Feb 07, 2020	BUY	$55.65 - $79.83 $1,279 - $1,836	23 Added 0.26%	8,741 $539,000
Q3 2019 Oct 31, 2019	BUY	$64.7 - $85.39 $51,113 - $67,458	790 Added 9.96%	8,718 $635,000
Q2 2019 Aug 02, 2019	SELL	$67.77 - $82.2 $21,076 - $25,564	-311 Reduced 3.77%	7,928 $0
Q1 2019 May 02, 2019	BUY	$45.83 - $70.54 $11,365 - $17,493	248 Added 3.1%	8,239 $0
Q4 2018 Feb 06, 2019	SELL	$41.17 - $56.44 $3,046 - $4,176	-74 Reduced 0.92%	7,991 $421,000
Q3 2018 Nov 01, 2018	SELL	$52.95 - $71.34 $81,913 - $110,362	-1,547 Reduced 16.09%	8,065 $449,000
Q2 2018 Aug 01, 2018	BUY	$56.38 - $68.08 $16,462 - $19,879	292 Added 3.13%	9,612 $673,000
Q1 2018 May 01, 2018	BUY	$56.98 - $72.41 $8,717 - $11,078	153 Added 1.67%	9,320 $565,000
Q4 2017 Feb 02, 2018	SELL	$53.3 - $74.56 $12,792 - $17,894	-240 Reduced 2.55%	9,167 $636,000
Q3 2017 Nov 06, 2017	BUY	$43.46 - $52.49 $408,828 - $493,773	9,407	9,407 $551,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account